Wall Street is positive on FibroGen Inc (FGEN). On average, analysts give FibroGen Inc a Hold rating. The average price target is $4.375, which means analysts expect the stock to gain by 333.17% over the next twelve months. That average ranking earns FibroGen Inc an Analyst Rating of 2, which is better than 2% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating FGEN a Hold today. Find out what this means to you and get the rest of the rankings on FGEN!